Sovremennaya vnutrimatochnaya kontratseptsiya

Cite item

Full Text


About the authors

I V Kuznetsova


  1. Межевитинова Е.А. Внутриматочная контрацепция. В кн.: Практическая гинекология (Клинические лекции). Под ред. В.И.Кулакова, В.Н.Прилепской. М.: МЕДпресс-информ, 2001; с. 587-601.
  2. Population Reference Bureau. Family planning worldwide. 2002 data sheet.
  3. D`Arcanges C. Worldwide use of intrauterine devices for contraception. Contraception 2007; 75: S2-7.
  4. Thonneau P, Goulard H, Goyaux N. Risk factors for intrauterine device failure: a review. Contraception 2001; 64: 33-7.
  5. Medical Eligibility Criteria for Contraceptive Use Third Edition, WHO, 2004; ISNB 92 4 156266 8 (NLM classification: WP 630).
  6. Stefanidis K, Drakakis P, Anastasiadou V et al. Screening and antibiotics before IUD insertion reduced PID. Eur J Contracept Reprod Health Care. Abstr 10th Cohgr Eur Soc Contracept 2008; 13 (2): 139-40.
  7. Theodoris T, Zalvanos A, Vavilis D et al. Cu-IUCD and accidental pregnancy. Twenty years experience. Eur J Contracept Reprod Health Care. Abstr 10th Cohgr Eur Soc Contracept 2008; 13 (2): 138.
  8. Batar A, Kuukankorpi M, Siljander M et al. Five-year clinical experiences with NovaT380 copper IUD. Contraception 2002; 66: 309-14.
  9. Cox M, Tripp S, Blacksell S. Clinical performance of the NovaT380 intrauterine device in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report. J Fam Plan Repr Health Care 2002; 28 (2): 69-72.
  10. Kulier R, Helmerhost FM, O`Brien P et al. Copper containing, framed intra-uterine devices for contraception. Cohrane Database Syst Rev 2006; 3: CD005347.
  11. French RS, Cowan FM, Mansour D et al. Levonorgestrel-releasing (20 microgram/day) intrauterine system (Mirena) compared with other methods of reversible contraceptive. BJOG 2000; 107: 1218-25.
  12. French RS, van Vilet H, Cowan FM et al. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev 2004: CD001776.
  13. Avecilla-Palau A, Moreno V. Uterine factors and risk of pregnancy in IUD users: a nested case-control study. Contraception 2003; 67: 33-7.
  14. Grimes D. Intrauterine device and upper-genital-tract infection. Lancet 2000; 356: 1013-9.
  15. Rodrigues da Cunha A, Dorea JG, Cantuaria A. An intrauterine device and maternal copper metabolism during lactation. Contraception 2001; 63: 37-9.
  16. Celen S, Moroy P, Sucak A et al. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Contraception 2004; 69: 279-82.
  17. Grimes D, Shulz K, van Vilet H, Stanwood N. Immediate postpartum insertion of intrauterine devices. Cochrane Database Syst Rev 2001; CD003036.
  18. Grimes D, Shulz K, Stanwood N. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev 2004; CD001777.
  19. Eroglu K, Akkuzu G, Vural G et al. Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-up. Contraception 2006; 74: 376-81.
  20. Ortyli N, Bulut A, Sahin T, Sivin I. Immediate postabortal contraception with the levonorgestrel intrauterine device, Norplant, and traditional methods. Contraception 2001; 63: 309-14.
  21. Pakarinen P, Toivonen J, Luukainen T. Randomized comparison of levonorgestrel- and cooper-releasing intrauterine systems immediately after abortion, with 5 years` follow-up. Contraception 2003; 68: 31-4.
  22. Bilian X. Chinese experience with intrauterine devices. Contraception 2007; 75: S31-4.
  23. Zhou L, Xiao B. Emergency contraception with multiload Cu-375 SL IUD: a multicenter clinical trial. Contraception 2001; 64: 107-12.

Copyright (c) 2012 Kuznetsova I.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies